Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database

PURPOSE: Prior studies have suggested that patients with stage II/III colon cancer receive similar benefit from intravenous (IV) fluoropyrimidine adjuvant therapy regardless of age. Combination regimens and oral fluorouracil (FU) therapy are now standard. We examined the impact of age on colon cance...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McCleary, Nadine J., Meyerhardt, Jeffrey A., Green, Erin, Yothers, Greg, de Gramont, Aimery, Van Cutsem, Eric, O'Connell, Michael, Twelves, Christopher J., Saltz, Leonard B., Haller, Daniel G., Sargent, Daniel J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2013
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3699725/
https://ncbi.nlm.nih.gov/pubmed/23733765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.49.6638
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados